APA (7th ed.) Citation

Patties, I., Kallendrusch, S., Böhme, L., Kendzia, E., Oppermann, H., Gaunitz, F., . . . Glasow, A. (2019, October). The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment. Journal of Experimental & Clinical Cancer Research.

Chicago Style (17th ed.) Citation

Patties, Ina, Sonja Kallendrusch, Lisa Böhme, Eva Kendzia, Henry Oppermann, Frank Gaunitz, Rolf-Dieter Kortmann, and Annegret Glasow. "The Chk1 Inhibitor SAR-020106 Sensitizes Human Glioblastoma Cells to Irradiation, to Temozolomide, and to Decitabine Treatment." Journal of Experimental & Clinical Cancer Research Oct. 2019.

MLA (9th ed.) Citation

Patties, Ina, et al. "The Chk1 Inhibitor SAR-020106 Sensitizes Human Glioblastoma Cells to Irradiation, to Temozolomide, and to Decitabine Treatment." Journal of Experimental & Clinical Cancer Research, Oct. 2019.